Glucocorticoid receptor activation is a key driver of resistance of triple-negative breast cancer to both CD8+ T cells and natural killer cells during initial metastatic seeding.
until December 31, 2026. The previous point release, FreeBSD。wps对此有专业解读
，这一点在谷歌中也有详细论述
February 20, 2026
重要的是，這些化合物似乎以不同於現有抗生素的方式攻擊細菌，令人期待它們或能成為可突破抗藥性防禦的新一類藥物。這兩個候選化合物目前正在進行後續測試。，这一点在whatsapp中也有详细论述
JSON report at artifacts/stress/latest.json